ArticleOncotarget2017

Anti-tumor activity of high-dose EGFR tyrosine kinase inhibitor and sequential docetaxel in wild type EGFR non-small cell lung cancer cell nude mouse xenografts.

Ning Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.